These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 19736626)
1. Future potential and status of selective sodium channel blockers for the treatment of pain. Priest BT Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7. Williams BS; Felix JP; Priest BT; Brochu RM; Dai K; Hoyt SB; London C; Tang YS; Duffy JL; Parsons WH; Kaczorowski GJ; Garcia ML Biochemistry; 2007 Dec; 46(50):14693-703. PubMed ID: 18027973 [TBL] [Abstract][Full Text] [Related]
3. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain. Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998 [TBL] [Abstract][Full Text] [Related]
4. [Recent advances in the structure-activity relationship study of small-molecule sodium channel blockers with analgesic effects]. Li W; Zhou Y; Liu HM; You QD Yao Xue Xue Bao; 2009 Feb; 44(2):101-8. PubMed ID: 19408676 [TBL] [Abstract][Full Text] [Related]
6. Sodium channels and nociception: recent concepts and therapeutic opportunities. Krafte DS; Bannon AW Curr Opin Pharmacol; 2008 Feb; 8(1):50-6. PubMed ID: 17964852 [TBL] [Abstract][Full Text] [Related]
7. Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. Lindia JA; Köhler MG; Martin WJ; Abbadie C Pain; 2005 Sep; 117(1-2):145-53. PubMed ID: 16061326 [TBL] [Abstract][Full Text] [Related]
8. Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. Gaida W; Klinder K; Arndt K; Weiser T Neuropharmacology; 2005 Dec; 49(8):1220-7. PubMed ID: 16182323 [TBL] [Abstract][Full Text] [Related]
9. Isoform-selective voltage-gated Na(+) channel modulators as next-generation analgesics. England S; Rawson D Future Med Chem; 2010 May; 2(5):775-90. PubMed ID: 21426202 [TBL] [Abstract][Full Text] [Related]
10. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457 [TBL] [Abstract][Full Text] [Related]
11. Sodium channel blockers for neuropathic pain. Zuliani V; Rivara M; Fantini M; Costantino G Expert Opin Ther Pat; 2010 Jun; 20(6):755-79. PubMed ID: 20384535 [TBL] [Abstract][Full Text] [Related]
13. Small molecules targeting sodium and calcium channels for neuropathic pain. Bear B; Asgian J; Termin A; Zimmermann N Curr Opin Drug Discov Devel; 2009 Jul; 12(4):543-61. PubMed ID: 19562650 [TBL] [Abstract][Full Text] [Related]
14. Imidazopyridines: a novel class of hNav1.7 channel blockers. London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692 [TBL] [Abstract][Full Text] [Related]
15. Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels. Zhou X; Dong XW; Crona J; Maguire M; Priestley T J Pharmacol Exp Ther; 2003 Aug; 306(2):498-504. PubMed ID: 12730276 [TBL] [Abstract][Full Text] [Related]
16. Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells. Dekker LV; Daniels Z; Hick C; Elsegood K; Bowden S; Szestak T; Burley JR; Southan A; Cronk D; James IF Eur J Pharmacol; 2005 Dec; 528(1-3):52-8. PubMed ID: 16325806 [TBL] [Abstract][Full Text] [Related]
17. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. Dick IE; Brochu RM; Purohit Y; Kaczorowski GJ; Martin WJ; Priest BT J Pain; 2007 Apr; 8(4):315-24. PubMed ID: 17175203 [TBL] [Abstract][Full Text] [Related]
18. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. John VH; Main MJ; Powell AJ; Gladwell ZM; Hick C; Sidhu HS; Clare JJ; Tate S; Trezise DJ Neuropharmacology; 2004 Mar; 46(3):425-38. PubMed ID: 14975698 [TBL] [Abstract][Full Text] [Related]
19. The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs? Silos-Santiago I Curr Opin Investig Drugs; 2008 Jan; 9(1):83-9. PubMed ID: 18183535 [TBL] [Abstract][Full Text] [Related]